Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.drugalcdep.2019.05.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy" [Radiother. Oncol. 190 (2024) 109985].
Radiother Oncol
January 2025
Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, PR China. Electronic address:
Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak - CORRIGENDUM.
Epidemiol Infect
January 2025
School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.
Corrigendum to "GmDof41 regulated by the DREB1-type protein improves drought and salt tolerance by regulating the DREB2-type protein in soybean" [Int. J. Biol. Macromol, 230 (2023) 123235].
Int J Biol Macromol
January 2025
National Key Facility for Crop Gene Resources and Genetic Improvement, Key Laboratory of Biology and Genetic Improvement of Triticeae Crops/Key Laboratory of Quality Evaluation and Nutrition Health of Agro-Products, Ministry of Agriculture and Rural Affairs, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100081, China; College of Agronomy, Jilin Agricultural University, Changchun 130118, China; National Nanfan Research Institute (Sanya), Chinese Academy of Agricultural Sciences/Hainan Yazhou Bay Seed Laboratory, Sanya 572024, China. Electronic address:
Corrigendum to "Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial" [Contemp Clin Trials 2024 Apr:139:107456, pgs 1-11].
Contemp Clin Trials
January 2025
Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, USA.
Corrigendum to "The first attempt in synthesis, identification, and evaluation of SEPT9 inhibitors on human oral squamous carcinomas" [Bioorg. Chem 154 (2025) 108068].
Bioorg Chem
January 2025
School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!